We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > aptuit

News List

Evotec buys Aptuit for nearly $300m pharmaceutical-technology
August 18, 2017
German company Evotec has completed the acquisition of Aptuit for a total consideration of approximately $300m to support its long-term strategy to be the industry partner of choice for external drug discovery and development innovation.
Evotec to Pay $300M for Aptuit contractpharma
August 01, 2017
Expands position as leading player in integrated outsourced drug discovery and development solutions
Aptuit announces agreement with Regulus Therapeutics June 15, 2017
Aptuit's strategic provider agreement with Regulus Therapeutics provides range of discovery, CMC and non-clinical services.
Aptuit, Regulus in Strategic Provider Pact contractpharma
June 13, 2017
To provide a range of discovery, CMC and non-clinical services